Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rewalk Robotics Ltd (RWLK)

Rewalk Robotics Ltd (RWLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,032
  • Shares Outstanding, K 60,025
  • Annual Sales, $ 5,510 K
  • Annual Income, $ -19,570 K
  • 60-Month Beta 2.30
  • Price/Sales 6.89
  • Price/Cash Flow N/A
  • Price/Book 1.22
Trade RWLK with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.29
  • Most Recent Earnings $-0.08 on 11/14/23
  • Next Earnings Date 02/22/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 +40.01%
on 01/02/24
1.3000 -19.22%
on 01/08/24
+0.2724 (+35.03%)
since 12/29/23
3-Month
0.6275 +67.35%
on 10/30/23
1.3000 -19.22%
on 01/08/24
+0.4151 (+65.37%)
since 10/27/23
52-Week
0.5604 +87.38%
on 05/02/23
1.3000 -19.22%
on 01/08/24
+0.1930 (+22.52%)
since 01/27/23

Most Recent Stories

More News
ReWalk: Q1 Earnings Snapshot

ReWalk: Q1 Earnings Snapshot

RWLK : 1.0501 (+6.07%)
ReWalk: Q4 Earnings Snapshot

ReWalk: Q4 Earnings Snapshot

RWLK : 1.0501 (+6.07%)
ReWalk: Q3 Earnings Snapshot

ReWalk: Q3 Earnings Snapshot

RWLK : 1.0501 (+6.07%)
ReWalk: Q2 Earnings Snapshot

ReWalk: Q2 Earnings Snapshot

RWLK : 1.0501 (+6.07%)
ReWalk Robotics (RWLK) Reports Q1 Loss, Misses Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of 12.50% and 38.50%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RWLK : 1.0501 (+6.07%)
MLAB : 119.28 (-1.88%)
ReWalk: Q1 Earnings Snapshot

ReWalk: Q1 Earnings Snapshot

RWLK : 1.0501 (+6.07%)
ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of -6.67% and 0.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VRAY : 0.0250 (-39.90%)
RWLK : 1.0501 (+6.07%)
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 0% and 6.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TMCI : 4.97 (+0.61%)
RWLK : 1.0501 (+6.07%)
Artivion (AORT) Q1 Earnings and Revenues Beat Estimates

Artivion (AORT) delivered earnings and revenue surprises of 166.67% and 2.15%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AORT : 23.52 (-1.22%)
RWLK : 1.0501 (+6.07%)
ReWalk Robotics (RWLK) Reports Q4 Loss, Tops Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -28.57% and 3.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

RWLK : 1.0501 (+6.07%)
AXDX : 1.0400 (+18.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Company's exoskeletons allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. It offers ReWalk...

See More

Key Turning Points

3rd Resistance Point 1.2267
2nd Resistance Point 1.1634
1st Resistance Point 1.1067
Last Price 1.0501
1st Support Level 0.9867
2nd Support Level 0.9234
3rd Support Level 0.8667

See More

52-Week High 1.3000
Last Price 1.0501
Fibonacci 61.8% 1.0175
Fibonacci 50% 0.9302
Fibonacci 38.2% 0.8429
52-Week Low 0.5604

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar